Baird Small/Mid Cap Growth Q1 2026 Commentary [Seeking Alpha]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Seeking Alpha
In short, relative weakness from both consumer discretionary and healthcare (particularly in March) offset stronger relative performance in technology and industrials. The strongest contributor to relative performance in the quarter was technology, as portfolio holdings were down roughly 5% compared to negative 14% for the benchmark. juststock/iStock via Getty Images Market Update Equities rallied to start the year, spurred by falling interest rates along with an uptick in economic activity and related company fundamentals. However, as March began, macro conditions became much less forgiving. U.S. military action against Iran, followed by escalation This article was written by Quick Insights Technology and industrials outperformed due to timely shifts into semiconductors and AI infrastructure, but consumer discretionary and healthcare underperformance offset these gains, resulting in -4.8% net return versus -3.5% for the benchmark. I see long-term growth in healthcare
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Forget Ozempic: This High-Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins [Yahoo! Finance]Yahoo! Finance
- DXCM STOCKHOLDER NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Investors to Contact the FirmGlobeNewswire
- A Look At Dexcom (DXCM) Valuation As Shares Lag And Fair Value Estimates Point Higher [Yahoo! Finance]Yahoo! Finance
- Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- DexCom's Quarterly Earnings Preview: What You Need to Know [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/12/26 - Beat
DXCM
Sec Filings
- 4/16/26 - Form 4
- 4/15/26 - Form ARS
- 4/15/26 - Form DEFA14A
- DXCM's page on the SEC website